Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
- PMID: 34073872
- PMCID: PMC8197255
- DOI: 10.3390/ijms22115533
Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
Abstract
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are common and devastating clinical disorders with high mortality and no specific therapy. Lipopolysaccharide (LPS) is usually used intratracheally to induce ALI in mice. The aim of this study was to examine the effects of an ultramicronized preparation of palmitoylethanolamide (um-PEA) in mice subjected to LPS-induced ALI. Histopathological analysis reveals that um-PEA reduced alteration in lung after LPS intratracheal administration. Besides, um-PEA decreased wet/dry weight ratio and myeloperoxidase, a marker of neutrophils infiltration, macrophages and total immune cells number and mast cells degranulation in lung. Moreover, um-PEA could also decrease cytokines release of interleukin (IL)-6, interleukin (IL)-1β, tumor necrosis factor (TNF)-α and interleukin (IL)-18. Furthermore, um-PEA significantly inhibited the phosphorylation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation in ALI, and at the same time decreased extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38/MAPK) expression, that was increased after LPS administration. Our study suggested that um-PEA contrasted LPS-induced ALI, exerting its potential role as an adjuvant anti-inflammatory therapeutic for treating lung injury, maybe also by p38/NF-κB pathway.
Keywords: acute lung injury; cytokines; inflammation; palmitoylethanolamide; ultramicronized.
Conflict of interest statement
Salvatore Cuzzocrea is a coinventor on patent WO2013121449 A8 (Epitech Group s.r.l.), which deals with methods and compositions for the modulation of amidases capable of hydrolyzing N-acylethanolamines employable in the treatment of inflammatory diseases. This invention is wholly unrelated to the present study. Moreover, Cuzzocrea is also, with Epitech Group, a coinventor on the patents EP 2 821 083, MI2014 A001495, and 102015000067344, which are unrelated to the study. The remaining authors report no conflicts of interest.
Figures






Similar articles
-
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model.Int Immunopharmacol. 2016 Feb;31:109-15. doi: 10.1016/j.intimp.2015.12.013. Epub 2015 Dec 19. Int Immunopharmacol. 2016. PMID: 26710167
-
Zerumbone from Zingiber zerumbet Ameliorates Lipopolysaccharide-Induced ICAM-1 and Cytokines Expression via p38 MAPK/JNK-IκB/NF-κB Pathway in Mouse Model of Acute Lung Injury.Chin J Physiol. 2018 Jun;61(3):171-180. doi: 10.4077/CJP.2018.BAG562. Chin J Physiol. 2018. PMID: 29962177
-
Ivermectin contributes to attenuating the severity of acute lung injury in mice.Biomed Pharmacother. 2022 Nov;155:113706. doi: 10.1016/j.biopha.2022.113706. Epub 2022 Sep 15. Biomed Pharmacother. 2022. PMID: 36116250
-
Protective effect of berberine against LPS-induced injury in the intestine: a review.Cell Cycle. 2022 Nov;21(22):2365-2378. doi: 10.1080/15384101.2022.2100682. Epub 2022 Jul 19. Cell Cycle. 2022. PMID: 35852392 Free PMC article. Review.
-
Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.Mol Neurobiol. 2013 Oct;48(2):340-52. doi: 10.1007/s12035-013-8487-6. Epub 2013 Jun 28. Mol Neurobiol. 2013. PMID: 23813098 Review.
Cited by
-
Modulation of NRF-2 Pathway Contributes to the Therapeutic Effects of Boswellia serrata Gum Resin Extract in a Model of Experimental Autoimmune Myocarditis.Antioxidants (Basel). 2022 Oct 28;11(11):2129. doi: 10.3390/antiox11112129. Antioxidants (Basel). 2022. PMID: 36358503 Free PMC article.
-
The role of fatty acid metabolism in acute lung injury: a special focus on immunometabolism.Cell Mol Life Sci. 2024 Mar 8;81(1):120. doi: 10.1007/s00018-024-05131-4. Cell Mol Life Sci. 2024. PMID: 38456906 Free PMC article.
-
Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia.Biomedicines. 2023 Mar 6;11(3):792. doi: 10.3390/biomedicines11030792. Biomedicines. 2023. PMID: 36979771 Free PMC article.
-
Research progress of mitochondrial dysfunction induced pyroptosis in acute lung injury.Respir Res. 2024 Nov 7;25(1):398. doi: 10.1186/s12931-024-03028-1. Respir Res. 2024. PMID: 39511593 Free PMC article. Review.
-
A Narrative Review of the Efficacy of Long COVID Interventions on Brain Fog, Processing Speed, and Other Related Cognitive Outcomes.Biomedicines. 2025 Feb 10;13(2):421. doi: 10.3390/biomedicines13020421. Biomedicines. 2025. PMID: 40002834 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous